MyAverix Finance
ST · Healthcare
EQL Pharma AB (EQL)
Drug Manufacturers - Specialty & Generic
EQL Pharma AB (EQL) is listed on ST in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EQL
EQL Pharma AB (EQL) — FAQ
What is EQL's P/E ratio?
The price-to-earnings (P/E) ratio for EQL Pharma AB (EQL) is 18.00 (data as of 2026-05-24).
Does EQL Pharma AB pay a dividend?
Dividend yield is not available in the current snapshot for EQL Pharma AB (EQL). Check the MyAverix Finance app for the latest dividend data.
What sector is EQL Pharma AB in?
EQL Pharma AB (EQL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is EQL listed on?
EQL is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.